Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology

Related Experiment Video

Updated: Aug 8, 2026

Intracellular Refolding Assay
07:18

Intracellular Refolding Assay

Published on: January 24, 2012

Michael W Graner1, Darell D Bigner

  • 1Duke University Medical Center, Pathology/Preston Robert Tisch Brain Tumor Center, 177 MSRB, Box 3156, Durham, NC, USA. michael.graner@duke.edu

Insights

Chaperones and heat-shock proteins are crucial in brain tumor biology and immunology. This review explores their potential as novel therapeutic targets for treating central nervous system (CNS) tumors.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Immunology

Background:

  • Central nervous system (CNS) tumors cause severe cognitive, motor, and personality impairments, often leading to mortality.
  • Current treatments for brain tumors have limited efficacy in altering disease progression.
  • Chaperones, also known as heat-shock proteins (HSPs), are increasingly recognized for their roles in cancer biology and immune responses.

Purpose of the Study:

  • To provide a comprehensive overview of the role of chaperones/heat-shock proteins in brain tumor treatment.
  • To update the current understanding of HSPs in neuro-oncology.
  • To discuss future therapeutic strategies targeting HSPs for CNS tumors.

Main Methods:

  • Literature review of studies on chaperones/heat-shock proteins in cancer.
  • Analysis of the involvement of HSPs in tumor biology and immunology.
  • Exploration of therapeutic potential and future directions in neuro-oncology.

Main Results:

  • Chaperones/heat-shock proteins are implicated in critical aspects of tumor development and immune evasion.
  • These proteins present promising opportunities for novel therapeutic interventions in various cancers.
  • Neuro-oncology is beginning to leverage the understanding of HSPs for brain tumor treatment.

Conclusions:

  • Chaperones/heat-shock proteins represent a significant area of interest for developing new treatments for brain tumors.
  • Targeting HSPs offers a potential avenue to overcome the limitations of current neuro-oncology therapies.
  • Further research into HSPs is crucial for advancing the treatment of CNS malignancies.

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...